Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials

MeSH terms

• Aged
• Ankle Brachial Index
• Aspirin / adverse effects
• Aspirin / therapeutic use*
• Cardiovascular Agents / adverse effects
• Cardiovascular Agents / therapeutic use*
• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control*
• Clinical Trials as Topic
• Diabetes Complications / prevention & control*
• Diabetes Mellitus, Type 2 / complications
• Diabetes Mellitus, Type 2 / drug therapy*
• Evidence-Based Medicine
• Female
• Humans
• Male
• Middle Aged
• Patient Selection
• Peripheral Arterial Disease / complications
• Peripheral Arterial Disease / diagnosis
• Peripheral Arterial Disease / drug therapy*
• Primary Prevention / methods*
• Time Factors
• Treatment Outcome